Dr. Amit Bar-Or, MD
Claim this profileUniversity of Pennsylvania
Studies Multiple Sclerosis
Studies Coronavirus
7 reported clinical trials
13 drugs studied
Affiliated Hospitals
Clinical Trials Amit Bar-Or, MD is currently running
CC-97540
for Multiple Sclerosis
This trial is testing a new drug called CC-97540 to see if it is safe and effective for people with relapsing or progressive multiple sclerosis. The goal is to find out if it can help manage symptoms or slow down the disease.
Recruiting1 award Phase 1
Stem Cell Transplant vs Best Available Therapy
for Multiple Sclerosis
This is a multi-center prospective rater-masked (blinded) randomized controlled trial of 156 participants, comparing the treatment strategy of Autologous Hematopoietic Stem Cell Transplantation (AHSCT) to the treatment strategy of Best Available Therapy (BAT) for treatment-resistant relapsing multiple sclerosis (MS). Participants will be randomized at a 1 to 1 (1:1) ratio. All participants will be followed for 72 months after randomization (Day 0, Visit 0).
Recruiting2 awards Phase 312 criteria
More about Amit Bar-Or, MD
Clinical Trial Related1 year of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Amit Bar-Or, MD has experience with
- ATA188
- CC-97540
- Fludarabine
- Cyclophosphamide
- Autologous Hematopoietic Stem Cell Transplantation
- Best Available Therapy (BAT)
Breakdown of trials Amit Bar-Or, MD has run
Multiple Sclerosis
Autoimmune Diseases
Systemic Lupus Erythematosus
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Amit Bar-Or, MD specialize in?
Amit Bar-Or, MD focuses on Multiple Sclerosis and Coronavirus. In particular, much of their work with Multiple Sclerosis has involved treating patients, or patients who are undergoing treatment.
Is Amit Bar-Or, MD currently recruiting for clinical trials?
Yes, Amit Bar-Or, MD is currently recruiting for 3 clinical trials in Philadelphia Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Amit Bar-Or, MD has studied deeply?
Yes, Amit Bar-Or, MD has studied treatments such as ATA188, CC-97540, Fludarabine.
What is the best way to schedule an appointment with Amit Bar-Or, MD?
Apply for one of the trials that Amit Bar-Or, MD is conducting.
What is the office address of Amit Bar-Or, MD?
The office of Amit Bar-Or, MD is located at: University of Pennsylvania, Philadelphia, Pennsylvania 19104-5127 United States. This is the address for their practice at the University of Pennsylvania.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.